Sudhan, D. R., Guerrero-Zotano, A., Won, H., Ericsson, P. G., Servetto, A., Huerta-Rosario, M., . . . Arteaga, C. L. (2020). Hyperactivation of TORC1 Drives Resistance to the Pan-HER Tyrosine Kinase Inhibitor Neratinib in HER2-Mutant Cancers. Cancer Cell.
استشهاد بنمط شيكاغوSudhan, Dhivya R., et al. "Hyperactivation of TORC1 Drives Resistance to the Pan-HER Tyrosine Kinase Inhibitor Neratinib in HER2-Mutant Cancers." Cancer Cell 2020.
MLA استشهادSudhan, Dhivya R., et al. "Hyperactivation of TORC1 Drives Resistance to the Pan-HER Tyrosine Kinase Inhibitor Neratinib in HER2-Mutant Cancers." Cancer Cell 2020.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.